The presence of micronized progesterone vaginal form Proginorm GESTA and oral form Proginorm OVO allows you to individually approach each case of the threat of termination of pregnancy or preterm birth, taking into account the associated pathologies and convenience for the patient. It is important to switch from one form to another, if necessary, to rapidly saturate the body with pregnant progesterone under conditions of gestagen insufficiency in order to eliminate the threat of termination of pregnancy or prolongation of pregnancy with the threat of preterm birth. The results of treatment correspond to the average indicators in the EU countries. The drug can be recommended for use in a wide range of obstetric practices, especially given its affordable market value and European quality in this difficult economic period for our country.